Shields Matthew sold $322K of TEVA
Shields Matthew (EVP, Global Operations) sold 9,989 shares of TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) at $32.19 ($0.32M total) on 2026-06-18.
How this was made
The 30-second read
Why it matters
The newest fact is the specific sale size, price, and post-transaction holdings (0 shares), which may slightly influence sentiment but does not change TEVA fundamentals in the text.
Market read
Traders may note the insider selling signal, but the disclosure alone is unlikely to be a standalone catalyst.
What to watch
No 10b5-1 plan is indicated, but the article also lacks context on total holdings history, tax events, or whether other insiders made offsetting buys.
Background
This is an SEC Form 4 insider transaction for TEVA, reported by Matthew Shields (EVP, Global Operations).
Ticker impact
TEVA disclosed an EVP Global Operations open-market sale of 9,989 shares at $32.1901 on 2026-06-18 via Form 4.
Likely limited near-term impact; any effect would be small and quickly absorbed unless followed by additional disclosures.
The filing is a routine Form 4 open-market sale with no 10b5-1 plan stated and no accompanying operational/financial guidance change.
Market effects
No sector read-across; this is company-specific insider transaction disclosure.
None indicated; TEVA is the only subject with a disclosed transaction.
Minimal; no deal, regulatory action, or operational update is described.
Counterpoint
The sale could be liquidity/portfolio rebalancing rather than a bearish signal, especially since the transaction is labeled open-market and the filing provides no stated reason.
Key entities
- issuerTEVA PHARMACEUTICAL INDUSTRIES LTD
Subject of the Form 4 insider transaction disclosure.
- insiderShields Matthew
EVP, Global Operations who sold 9,989 shares.
